Table 2. HMO profiles by secretor–Lewis status.
| HMO profiles (mg/L) | Secretor status† | Lewis status† | Secretor–Lewis status‡ | |||
|---|---|---|---|---|---|---|
| Secretor positive | Weak secretor | Lewis positive | Lewis negative | Secretor+newis+ | Secretor+newis– | |
| 2’FL | 2,292 (809–4,891)* | 1,900 (49–2,670)* | 2,150 (64–3,284) | 1,969 (65–5,643) | 2,150 (64–3,284) | 1,969 (85–5,643) |
| LNFP I | 591 (169–1,503) | 394 (59–977) | 490 (150–1,398) | 340 (35–994) | 490 (150–1,398) | 341 (35–994) |
| LNT | 106 (50–185) | 109 (65–215) | 111 (65–215) | 104 (25–160) | 111 (65–215) | 104 (25–160) |
| LNnT | 76 (36–119) | 65 (38–102) | 76 (38–118) | 63 (29–87) | 76 (38–118) | 63 (29–87) |
| 3’SL | 188 (132–261) | 188 (142–225) | 190 (140–249) | 177 (58–209) | 190 (140–249) | 177 (58–209) |
| 6’SL | 185 (132–260) | 188 (142–223) | 188 (139–246) | 178 (56–208) | 188 (139–246) | 178 (56–208) |
Values are presented as median (interquartile range).
HMO: human milk oligosaccharides, 2’FL: 2’-fucosyllactose, LNFP I: lacto-N-fucopentaose I, LNT: lacto-N-tetraose, LNnT: lacto-N-neotetraose, 3’SL: 3’-sialyllactose, 6’SL: 6’-sialyllactose.
*p-value<0.05.
†Mann-Whitney test.
‡Kruskal-Wallis test.